Inspectors sent to Florence hospital over GD treatment

(ANSA) - ROME, JAN 24 - The government has sent inspectors to Florence's Careggi to look into its treatment of minors with gender dysphoria (GD) and the use of drug triptorelin.
    GD regards people who experience a mismatch between their gender identity and their sex assigned at birth.
    Triptorelin is sometimes used to delay puberty in patients with GD to give them time to gain awareness of their gender identity and prepare for the psychological, medical, developmental, social and legal issues that may lie ahead of them.
    "It's just a check of what has been done and whether the regulations have been followed," said Health Minister Orazio Schillaci on Wednesday in relation to the inspection.
    "It is absolutely not a punitive gesture".
    Mara Campitiello, the head of the minister's technical secretariat, told ANSA that Schillaci will receive the inspectors' report within 15 days. (ANSA).